揭示抑制剂中含量和精选异循环的动态:一个ceteris paribus的方法
Vijay H Masand1, Sami Al-Hussain2, Abdullah Y Alzahrani3
1Department of Chemistry, Vidya Bharati Mahavidyalaya, Amravati, India.
Expert opinion on drug discovery
|June 20, 2024
概括
大多数血栓抑制剂含有不到五个原子. 罗利丁,皮里丁和皮佩里丁是有效的抗血素药物中常见的N-异环,指导着未来的药物发现.
科学领域:
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
- 计算化学计算化学
背景情况:
- 血抑制剂对于抗凝固疗法至关重要.
- 优化药物发现管道对于血栓激素抑制剂需要了解分子设计原则.
- 和N-异环在许多抗血栓激素药物中普遍存在.
研究的目的:
- 分析抑制剂中原子和N-异环的发生和分布.
- 为优化化合物在抗血栓药物发现中提供见解.
主要方法:
- 分析了4359种血栓抑制剂的数据集.
- 原子的分类包括环,非环,芳香和非芳香类型.
- 对精选的芳香和性N-异环环的分析.
主要成果:
- 大约62%的血栓激素抑制剂有五个或更少的原子.
- 常见的N-异环包括pyrrolidine (23.24%),pyridine (20.56%),以及piperidine (16.10%).
- 发现的其他显著的N-异环是提亚 (9.61%) 和伊米达 (7.36%).
结论:
- 活性血栓激素抑制剂经常含有大约五个原子.
- 像pyrrolidine,pyridine和piperidine这样的N-异环的组合是有效抑制剂的特征.
- 这一分析为开发新型抗血栓剂提供了有价值的指导.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Therapeutic Index
4.2K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
4.2K
The Equilibrium Binding Constant and Binding Strength
12.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.9K
Protein-Drug Binding: Mechanism and Kinetics
406
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
406
Time Course of Drug Effect
2.0K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.0K


